Relationship Between Fertility Hormone Patterns and Pregnancy Rates.
1 other identifier
observational
5,000
1 country
1
Brief Summary
The purpose of this study is to determine if certain patterns of hormone levels during the menstrual cycle are correlated with different pregnancy outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2020
CompletedFirst Submitted
Initial submission to the registry
July 30, 2021
CompletedFirst Posted
Study publicly available on registry
September 2, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedMarch 19, 2024
March 1, 2024
4.1 years
July 30, 2021
March 17, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
self reported pregnancy
Questionnaire used to assess if positive Proov test strips measuring urine PDG correlate with increased rates of self reported pregnancy
Two menstrual cycle, up to 45 days each
Secondary Outcomes (1)
self reported first trimester pregnancy loss
Three months
Study Arms (1)
Proov test strip users that record results with the Proov app
Participants using Proov test strips along with the Proov app who have logged at least one complete cycle will be asked to complete an online survey about fertility test results and current/previous pregnancy status. They will also be asked cycle history (irregular vs regular, cycle length), fertility testing (partners semen analysis results, AMH level, HSG results), possible fertility medications taken or prescribed, age, race, smoking status, and BMI.
Interventions
Rapid response urine PdG, FSH, E1G and LH test strips, Proov
Eligibility Criteria
Females age 18 - no limit who are using, or have used, the Proov hormone test strips and the Proov app for at least one full cycle.
You may qualify if:
- Female
- Age 18 - no limit
- Have completed one full cycle using the Proov app
You may not qualify if:
- Male
- Have not completed one full cycle using the Proov app
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- MFB Fertilitylead
Study Sites (1)
MFB Fertility
Boulder, Colorado, 80301, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Amy Beckely, PhD
MFB Fertility
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 30, 2021
First Posted
September 2, 2021
Study Start
March 1, 2020
Primary Completion
April 1, 2024
Study Completion
April 1, 2026
Last Updated
March 19, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share
only cohort data will be released